Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel A Simon

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
ACP Journal Club|November 5, 2003
Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemiaJoel A Simon
Archives of Internal Medicine|December 3, 2002
Combined vitamin E and vitamin C supplement use and risk of cardiovascular disease mortalityJoel A Simon
ACP Journal Club|May 3, 2005
Review: n-3 fatty acids do not reduce mortality, cardiovascular events, or cancer in patients at risk for cardiovascular diseaseJoel A Simon
ACP Journal Club|March 4, 2008
Review: vitamin D supplementation decreases all-cause mortality in adults and older individualsJoel A Simon
Archives of Internal Medicine|April 27, 2011
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking"Joel A Simon
ACP Journal Club|July 2, 2005
Review: high-dose vitamin E supplementation is associated with increased all-cause mortalityJoel A Simon
Annals of Internal Medicine|November 19, 2009
ACP Journal Club: Review: Evidence for the effectiveness of vitamin D and calcium for reducing CV outcomes, cancer, and death is limitedJoel A Simon
ACP Journal Club|September 4, 2007
An intermediate body mass index (23 to 30 kg/m 2) was associated with the most favorable mortality in older womenJoel A Simon
ACP Journal Club|September 5, 2002
Review: n-3 polyunsaturated fatty acids reduce fatal MI, sudden death, and overall mortality in coronary heart diseaseJoel A Simon
Atherosclerosis|June 20, 2006
Sterol esters, stanol esters, and vascular diseaseJoel A Simon
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
ACP Journal Club|November 5, 2003
Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemiaJoel A Simon
Archives of Internal Medicine|December 3, 2002
Combined vitamin E and vitamin C supplement use and risk of cardiovascular disease mortalityJoel A Simon
ACP Journal Club|May 3, 2005
Review: n-3 fatty acids do not reduce mortality, cardiovascular events, or cancer in patients at risk for cardiovascular diseaseJoel A Simon
ACP Journal Club|March 4, 2008
Review: vitamin D supplementation decreases all-cause mortality in adults and older individualsJoel A Simon
Archives of Internal Medicine|April 27, 2011
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking"Joel A Simon
ACP Journal Club|July 2, 2005
Review: high-dose vitamin E supplementation is associated with increased all-cause mortalityJoel A Simon
Annals of Internal Medicine|November 19, 2009
ACP Journal Club: Review: Evidence for the effectiveness of vitamin D and calcium for reducing CV outcomes, cancer, and death is limitedJoel A Simon
ACP Journal Club|September 4, 2007
An intermediate body mass index (23 to 30 kg/m 2) was associated with the most favorable mortality in older womenJoel A Simon
ACP Journal Club|September 5, 2002
Review: n-3 polyunsaturated fatty acids reduce fatal MI, sudden death, and overall mortality in coronary heart diseaseJoel A Simon
Atherosclerosis|June 20, 2006
Sterol esters, stanol esters, and vascular diseaseJoel A Simon
Pageof 4